Skip to main content

Verdence Capital Advisors LLC

Position in ABT — Abbott Laboratories

CIK 1719305 HUNT VALLEY, MD

Position in ABT

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$1,628,140
-$1,055,321 QoQ
Shares Held
15,858
-26.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 53.26018413419094.ToString("F0")% Shared 0.ToString("F0")% None 46.73981586580906.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Dec 31, 2021
CallValue
$56,296
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Verdence Capital Advisors LLC holds $8,182,815 across 12 Medical Devices names. ABT ranks #2 (19.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABT
Abbott Laboratories
This page
15,858 $1,628,140

All Filings in ABT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,628,140 15,858
2025-12-31 $2,683,461 21,418
2025-09-30 $3,918,682 29,257
2025-06-30 $3,315,515 24,377
2025-03-31 $3,143,937 23,701
2024-12-31 $3,408,004 30,130
2024-09-30 $3,309,368 29,027
2024-06-30 $2,929,015 28,188
2024-03-31 $3,095,984 27,239
2023-12-31 $3,000,288 27,258
2023-09-30 $2,116,269 21,851
2023-06-30 $2,098,089 19,245
2023-03-31 $2,015,985 19,909
2022-12-31 $1,776,511 16,181
2022-09-30 $2,255,088 23,306
2022-06-30 $2,512,639 23,126
2022-03-31 $2,525,565 21,338
2021-12-31 $56,296 400
2021-12-31 $2,506,579 17,810
2021-09-30 $2,035,616 17,232
2021-06-30 $2,009,646 17,335
2021-03-31 $2,074,310 17,309
2020-12-31 $1,699,503 15,522
2020-09-30 $1,273,746 11,704
2020-06-30 $944,746 10,333
2020-03-31 $764,322 9,686